AU2002239777A1 - Novel therapeutics for heart failure and aging - Google Patents
Novel therapeutics for heart failure and agingInfo
- Publication number
- AU2002239777A1 AU2002239777A1 AU2002239777A AU3977702A AU2002239777A1 AU 2002239777 A1 AU2002239777 A1 AU 2002239777A1 AU 2002239777 A AU2002239777 A AU 2002239777A AU 3977702 A AU3977702 A AU 3977702A AU 2002239777 A1 AU2002239777 A1 AU 2002239777A1
- Authority
- AU
- Australia
- Prior art keywords
- aging
- heart failure
- novel therapeutics
- therapeutics
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010019280 Heart failures Diseases 0.000 title 1
- 230000032683 aging Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4716—Muscle proteins, e.g. myosin, actin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24398500P | 2000-10-27 | 2000-10-27 | |
| US60/243,985 | 2000-10-27 | ||
| PCT/US2001/051272 WO2002045659A2 (en) | 2000-10-27 | 2001-10-26 | Novel therapeutics for heart failure and aging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002239777A1 true AU2002239777A1 (en) | 2002-06-18 |
Family
ID=22920925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002239777A Abandoned AU2002239777A1 (en) | 2000-10-27 | 2001-10-26 | Novel therapeutics for heart failure and aging |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002239777A1 (en) |
| WO (1) | WO2002045659A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7378509B2 (en) | 2003-12-02 | 2008-05-27 | Anesiva, Inc. | NF-kappaB oligonucleotide decoy molecules |
| JP6782716B2 (en) * | 2015-06-25 | 2020-11-11 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Cell-based assay to reveal antibody or ligand binding and function |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284932A (en) * | 1990-09-07 | 1994-02-08 | The Cleveland Clinic Foundation | Process for purifying and characterizing myotrophia, a novel peptide that regulates myocardial growth |
| US6153423A (en) * | 1997-09-19 | 2000-11-28 | Incyte Pharmaceuticals, Inc. | Human myotrophin |
-
2001
- 2001-10-26 WO PCT/US2001/051272 patent/WO2002045659A2/en not_active Ceased
- 2001-10-26 AU AU2002239777A patent/AU2002239777A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002045659A9 (en) | 2003-08-07 |
| WO2002045659A2 (en) | 2002-06-13 |
| WO2002045659A3 (en) | 2005-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001260327A1 (en) | Chair | |
| AU2002227441A1 (en) | Biocompatible adhesives | |
| AU6906800A (en) | Membrane associated proteins | |
| AU2001264600A1 (en) | Labor chair | |
| AU2001273164A1 (en) | Membrane associated protein zupari | |
| AU2001238359A1 (en) | Membranes | |
| AU1557901A (en) | Chair | |
| AU2001234178A1 (en) | Modified bdnf | |
| AU2539101A (en) | Profile splitting | |
| AU1653401A (en) | Combination mattress | |
| AU2001252200A1 (en) | Chair | |
| AU2001273208A1 (en) | Proteins associated with aging | |
| AU2002239777A1 (en) | Novel therapeutics for heart failure and aging | |
| AU775742C (en) | Denture adhesive | |
| AU6113299A (en) | Furniture construction | |
| AU2516399A (en) | Bedframe | |
| AU2002224783A1 (en) | Office chair | |
| AU2002215030A1 (en) | Chair | |
| AU1526501A (en) | Chair | |
| AU3850900A (en) | Wood structure | |
| AU2001221475A1 (en) | Wood air-brick | |
| AU3816400A (en) | Structure | |
| AU5387299A (en) | Dismountable chair consisting of two frames | |
| AU2411401A (en) | Mattress | |
| AU5458799A (en) | Furniture construction |